Detection of the specific IgM and IgA circulating in sera of multiple sclerosis patients: Interest and perspectives;Intérêt de l'évaluation d'IgM et d'IgA spécifiques circulant dans le serum de malades atteints de sclérose en plaques (SEP)

Immuno-Analyse et Biologie Specialisee

Volumn 17, Issue 5, 2002, Pages 302-310

  Geffard, M ^a   Bodet, D ^a   Martinet, Y ^b   Dabadie, M P ^c  

^a Ecole Nationale Superieure de Chimie et de Physique de Bordeaux   (France)

^b IDRPHT   (France)

^c Immunochemistry Department   (France)

Author keywords

Biological follow up; Circulating antibodies; Multiple sclerosis; Sera

Indexed keywords

BACTERIAL ANTIGEN; FATTY ACID; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ANTIBODY DETECTION; BLOOD ANALYSIS; DISEASE COURSE; FOLLOW UP; HAFNIA ALVEI; HUMAN; KLEBSIELLA PNEUMONIAE; MORGANELLA MORGANII; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS PUTIDA; RELAPSE; REMISSION; REVIEW;

EID: 1042301128     PISSN: 09232532     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-2532(02)01214-0     Document Type: Article

References (56)

1. Abramsky O., Lisak R.P., Silberberg D.H., Pleasure D.H. Antibodies to oligodendroglia in patients with multiple sclerosis. N Engl J M. 297:1977;1207-1211.
2. Amara A., Chaugier C., Geffard M. Autoantibodies directed against conjugated fatty acids in sera of HIV-1 infected patients. AIDS. 8:1994;711-713.
3. Arnon R., Crisp E., Kelley R., Allison G., Myers L., Tourtelotte W. Anti-ganglioside antibodies in multiple sclerosis. J Neurol Sci. 46:1980;179-186.
4. Battistini L., Fischer F.R., Raine C.S., Brosnan C.F. CD1b is expressed in multiple sclerosis lesions. J of Neuroimmunology. 67:1996;145-151.
5. Bo L., Dawson T.M., Wesselingh S., Mork S., Choi S., Pei Ann Kong D., Hanley D., Trapp B.D. Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains. Annals of Neurology. 36:1994;778-786.
6. Boullerne A., Petry K.G., Meynard M., Geffard M. Indirect evidence for NO involvement in multiple sclerosis by characterization of circulating antibodies directed against conjugated S-nitrosocysteine. J of Neuroimmunol. 60:1995;117-124.
7. Boullerne A.I., Petry K.G., Geffard M. Circulating antibodies directed against conjugated fatty acids in sera of patients with multiple sclerosis. J of Neuroimmunol. 65:1996;75-81.
8. Boullerne A. Caractérisation d'anticorps circulants dirigés contre des néo-épitopes dans la Sclérose en Plaques et l'Encéphalite Allergique Expérimentale. 1996;. (thèse).
9. Bradford M. A rapid and sensitive method for the quantitative of microgram of protein utilizing the principle of protein-dye binding. Anal Biochem. 72:1976;248-254.
10. Chofflon M., Juillard C., Juillard P., Gauthier G., Grau G.E. Tumor necrosis factor production as a possible predictor of relapse in patients with multiple sclerosis. European cytokine network. 3:1992;523-531.
11. Daverat P., Geffard M., Orgogozo J.M. Identification and characterization of anti-conjugated azelaic acid antibodies in multiple sclerosis. J of Neuroimmunology. 22:1989;129-134.
12. De Groot C.A., Ruuls S.R., Theeuwes J.W.M., Dukstra C.D., Van Der Valk P. Immunocytochemical characterization of the expression of inducible and constitutive isoforms of nitric oxide syntase in demyelinating multiple sclerosis lesions. J of Neuropathology and Experimental Neurology. 56:1997;10-20.
13. Fagarasan S., Honjo T. T-independent immune response: new aspects of B cell biology. Science. 290:2000;89-92.
14. Faiderbe S., Chagnaud J.L., Wafflart J., Geffard M. Auto-anticorps dirigés contre un lipide membranaire dans les sérums de malades porteurs de tumeurs malignes. CRAS. 310:1990;49-52.
15. Faiderbe S., Chagnaud J.L., Charrier M.C., Peyron M.A., Wafflart J., Geffard M. Auto-antibodies directed against lipid membrane components in sera of patients with malignant tumors. Cancer Detection and Prevention. 15:1991;199-203.
16. Faiderbe S., Chagnaud J.L., Geffard M. Anti-phosphoinositide autoantibodies in sera of cancer patients: Isotypic and immunochemical characterization. Cancer Letters. 66:1992;35-41.
17. Fredrikson S., Michelsberg J., Hillert J., Wang Z., Sun J.B., Olerup O., Olsson T., Link H. Conjugal multiple sclerosis: immunogenetic characterization and analysis of T-and B-cell reactivity to myelin proteins. Neurology. 42:1992;577-582.
18. Fumarola D. Multiple Sclerosis and Borrelia Burgdorferi. The Lancet. 1986;575.
19. Geffard M., Buijs R.M., Seguela P., Pool C.W., Le Moal M. First demonstration of highly specific and sensitive antibodies against dopamine. Brain Research. 294:1984;161-165.
20. Geffard M., Seguela P., Heinrich-Rock A.M. Antisera against catecholamines: specificity studies and physicochemical data for anti-dopamine and p-tyramine antibodies. Molecular Immunology. 21:1984;515-522.
21. Geffard M., Kah O., Onteniente B., Seguela P., Le Moal M., Delaage M.A. Antibodies to dopamine: radioimmunological study of specificity in relation to immunocytochemistry. J Neurochem. 42:1984;1593-1599.
22. Geffard M., Seguela P., Buijs R.M. Immunorecognition of anti-serotonin antibodies by using a radiolabelled ligand. Neurosci Lett. 50:1984;217-222.
23. Geffard M., Rock A.M., Seguela P. Antibodies against small neurotransmitter molecules. Immunocytochemistry and neurotransmitter binding. ENA. Workshop, Brain Research Institute of Amsterdam. 1984;9-13.
24. Geffard M., Vieillemaringe J., Heinrich-Rock A.M., Duris P. Anti-acetylcholine antibodies and first immunocytochemical application in insect brain. Neurosci Lett. 57:1985;1-6.
25. Geffard M., Dulluc J., Heinrich-Rock A.M. Antisera against the indolealkylamines: tryptophan, 5-hydroxytryptophan, 5-hydroxytryptamine, 5-methoxytryptophan and 5-methoxytryptamine tested by an ELISA method. J Neurochem. 44:1985;1221-1228.
26. Geffard M., Heinrich-Rock A.M., Dulluc J., Seguela P. Antisera against small neurotransmitter-like molecules. Neurochem International. 7:1985;403-413.
27. Geffard M., Mc Rae Degueurce A., Souan M.L. Immunocytochemical detection of acetylcholine in the rat central nervous system. Science. 229:1985;77-79.
28. Geffard M., Bodet D., Claudepierre P., Metzger J.M., Sibilia J. Anticorps sériques circulants dirigés contre des antigènes modifiés par le NO dans les affections neurologiques et rhumatismales. Immunoanal. Biol Spéc. 13:1998;209-217.
29. Genain C.P., Cannella B., Hauser S.L., Raine C.S. Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nature Medicine. 5:1999;170-175.
30. Hillert J., Leng C., Olerup O. T-cell receptor a chain germline gene polymorphisms in multiple sclerosis. Neurology. 42:1992;80-84.
31. Johnson A., Bornstein M. Myelin binding antibodies in vitro. Immunoperoxidase studies with experimental allergic encephalomyelitis. Anti-galactocerebroside and multiple sclerosis sera. Brain Research. 159:1978;173-182.
32. Le Gac P. Rickettsioses, pararickettsioses et système nerveux. Ann Ist Super Sanita. 10:1974;275-296.
33. Lisak R., Zweiman B., Burns J., Rostami A., Silberberg D. Immune responses to myelin antigens in multiple sclerosis. Ann NY Acad Sci. 1984;221-230.
34. Macpherson A.J., Gatto D., Sainsbury E., Harriman G.R., Hengartner H., Zinkernagel R.M. A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal bacteria. Science. 288:2000;2222-2226.
35. Maneta-Peyret L., Daverat P., Geffard M., Cassagne C., Orgogozo J.M. Natural seric anti-fatty acid antibodies in multiple sclerosis. Neurosci Lett. 80:1987;235-239.
36. Martin R., Mc Farland H.F., Mc Farlin D.E. Immunological aspects of demyelinating diseases. Annu Rev. Immunol. 10:1992;153-187.
37. Martin R., Whitaker J.N., Rhame L., Goodin R.R., Mc Farland H.F. Citrulline containing myelin basic protein is recognized by T-cell lines derived from multiple sclerosis patients and healthy individuals. Neurology. 44:1994;123-129.
38. Okomo-Assoumou M.C., Geffard M., Daulouede S., Chaugier C., Lemesre J.L., Vincendeau P. Circulating antibodies directed against tryptophan-like epitopes in sera of patients with human African trypanosomiasis. Am J Trop Med Hyg. 52:1995;461-467.
39. Oksenberg J.R., Panzara M.A., Begovich A.B., Mitchell D. Selection for T-cell receptor Vb-Db-J-b gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis. Nature. 362:1993;68-70.
40. Olerup O., Hillert J., Fredrikson S., Olsson T., Kam-Hansen S., Moller E., Carlsson B., Wallin J. Primarily chronic progressive and relapsing/ remitting multiple sclerosis: two immunogenetically distinct disease entities. Proc Natl Acad Sci USA. 86:1989;7113-7117.
41. Ozawa K., Suchanek G., Breitschopf H., Bruck W., Budka H., Jellinger K., Lassman H. Patterns of oligodendroglia pathology in multiple sclerosis. Brain. 117:1994;1311-1322.
42. Panitch H., Hooper C., Johnson K. Antibody to myelin basic protein. Measurement in patients with multiple sclerosis and subacute sclerosing panencephalitis. Arch Neurol. 37:1980;206-209.
43. Paterson P., Day E., Whitacre C., Berenberg R., Harter D. Endogenous myelin basic protein serum factors (MBP-SFS) and anti-MBP antibodies in humans. Occurence in sera of clinically well subjects and patients with multiple sclerosis. J Neurol Sc. 52:1981;37-51.
44. Poser C.M., Paty B.W., Scheinberg L., Mc Donald I., Davis F., Ebers G.C., Johnson K.P., Sibley W.A., Silberberg D.H., Tourtelotte W.W. New diagnostic criteria for multiple sclerosis: guideliness for Research Protocols. Annals of Neurology. 13:1983;227-231.
45. Ryberg B., Baumann N.A. Different types of antibrain antibodies in multiple sclerosis. Studies employing myelin-deficient mutants of mice. Journal of the Neurological Sciences. 58:1983;351-355.
46. Salvetti M., Buttinelli C., Ristori G., Carbonari M., Cherchi M., Fiorelli M., Grasso M.G., Toma L., Possilli C. T-lymphocyte reactivity to the recombinant mycobacterial 65 and 70kDa heat shock proteins in multiple sclerosis. J of Autoimmunity. 5:1992;691-702.
47. Souan M.L., Geffard M., Lebrun-Grandie P., Orgogozo J.M. Detection of anti-acetylcholine antibodies in myasthenic patients. Neurosc Letters. 64:1986;23-28.
48. Spadaro M., Amendolea M.A., Mazzucconi M.G., Fantozzi R., Di Lello R., Zngari P., Masala C. Autoimmunity in multiple sclerosis: study of a wide spectrum of autoantibodies. Multiple Sclerosis. 5:1999;121-125.
49. Stroncek D.F., Kline W.E., Clai M.E., Plachta L.B., Stricker R.B., Hollander H., Greenspan J.S., Skubitz K.M. Antibodies to granulocytes in patients infected with human immunodeficiency virus. J Lab Clin M. 119:1992;724-731.
50. Stuber A., Martin R., Stone L.A., Maloni H., Mc Farland H.F. Expression pattern of activation and adhesion molecules on peripheral blood CD4+ T-lymphocytes in relapsing-remitting multiple sclerosis patients: a serial analysis. Journal of Neuroimmunology. 66:1996;147-151.
51. Utz U., Biddison W.E., Mc Farland H.F., Mc Farlin D.E., Flerlage M., Martin R. Skewed T-cell receptor repertoire in genetically identical twins correlates with multiple sclerosis. Nature. 364:1993;243-247.
52. Vega-Agapito V., Almeida A., Heales S.J.R., Medina J.M., Bolanos J.P. Peroxynitrite anion stimulates arginine release from cultured rat astrocytes. Journal of Neurochemistry. 73:1999;1446-1452.
53. Warren K.G., Catz I. Cerebrospinal fluid autoantibodies to myelin basic protein in multiple sclerosis patients. J Neurol Sci. 91:1989;143-151.
54. Washington R., Burton J., Todd R.F., Newman W., Dragovic L., Dore-Duffy P. Expression of immunologically relevant endothelial cell activation antigens on isolated central nervous system microvessels from patients with multiple sclerosis. Ann Neurol. 35:1994;89-97.
55. Zanetta J.P., Warter J.M., Kuchler S., Marschal P., Rumbach L., Lehmann S., Tranchant C., Reeber A., Vincendon G. Antibodies to cerebellar soluble lectin CSL in multiple sclerosis. The Lancet. 335:1990;1482-1484.
56. Zipp F., Weber F., Huber S., Sotgiu S., Czlonkowska A., Holler E., Albert E., Weiss E.H., Wekerle H., Hohlfeld R. Genetic control of multiple sclerosis: increased production of lymphotoxin and tumor necrosis factor-alpha by hla-dr2+ t cells. Annals of Neurology. 38:1995;723-730.